Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

HintMD

Explore full profile

Leading cloud-based patient engagement and commerce platform for medical aesthetic practitioners

Pleasanton, United StatesFounded 2014Health Tech & Medtech
Valuation $50–100M Last recorded · 2018
Revenue $1–10M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for HintMD and the history behind them.

About HintMD

HintMD operates in the medical aesthetics market, offering a fintech platform designed to improve practice management and patient outcomes. The platform provides seamless, simple, and smart payment solutions that empower aesthetic practices to enhance their economic performance and management analytics. HintMD serves aesthetic practices by offering patient subscription models and practice loyalty programs, which help to improve practice economics and patient satisfaction. The business model revolves around providing a vertically integrated payments platform that aligns with the vision of building a prestige aesthetics franchise. HintMD generates revenue through subscription fees and transaction-based charges for its payment solutions. The company aims to transform both patient and practice experiences by delivering meaningful outcomes through its products and services.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2014
Headquarters
Pleasanton, United States
Employees
6
Open positions
None listed
Dealroom signal
69.0/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Patient Care, Hard Tech
Client focus
b2b

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Jul 2020 $0 — Revance Therapeutics —
EARLY VC✓Equity / VC Dec 2018 $10M $40M Undisclosed —
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022
2021
2020 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

HintMD website traffic

Latest recorded traffic for HintMD is 300 monthly website visits, up 3.4% over the last three months. HintMD's team declined 57.1% over the past year.

Latest monthly visits300 3-month web change+3.4% 1-year team growth-57.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Other known investors1 additional known investor

  • Revance Therapeutics
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Pleasanton HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about HintMD on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See HintMD’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.